| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |